Document Detail


Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: A pilot study.
MedLine Citation:
PMID:  22309978     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Drug-induced parkinsonism (DIP) is seen in one third of patients exposed to antipsychotic drugs and may lead to complications related to dysphagia and falls. Aside from skilled neurological examination, no tool has been validated to facilitate detection and follow-up. OBJECTIVE: In this pilot study, three validated screening instruments were tested in an age-biased cohort of schizophrenia patients, including four items of the Liverpool University Neuroleptic Side-Effects Rating Scale (LUNSERS) and two brief questionnaires designed for community survey of parkinsonism. METHOD: Fifty-six subjects living with chronic schizophrenia between 50 and 75years of age underwent a motor evaluation along the original Unified Parkinson's Disease Rating Scale-section III and answered questions along the selected screening instruments, and results compared to those of 16 patients with Parkinson's disease (PD) and 15 neurologically unimpaired volunteers. Odds ratios, sensitivity, specificity, and their 95% confidence intervals, were calculated. RESULTS: All three screening instruments correctly identified the PD state and distinguished PD from healthy participants. Eighteen (32%) schizophrenic patients displayed objective motor signs of parkinsonism. A single item of the LUNSERS (shakiness) significantly distinguished DIP from DIP-free patients, with a sensitivity of 61.1% and a specificity of 83.3%. The positive predictive value was 63.5% and the negative predictive value was 81.9%. The two other screening methods showed insufficient predictive value. CONCLUSION: Apart from a single query on shakiness, none of the tools examined were adequate to screen for DIP in patients treated for schizophrenia. A different instrument is necessary to monitor this important adverse effect in schizophrenia.
Authors:
Pierre J Blanchet; Louise Normandeau; Pierre H Rompré
Related Documents :
22416668 - Regional cerebral blood flow patterns in patients with freezing of gait due to lacunar ...
21911698 - Laboratory abnormalities in patients with myotonic dystrophy type 2.
189658 - Regression and progression of early femoral atherosclerosis in treated hyperlipoprotein...
22102318 - Smokers with active crohn's disease have a clinically relevant dysbiosis of the gastroi...
20153468 - Evaluation of erythrocyte band 3 phosphotyrosine level, glutathione content, ca-125, an...
18589058 - Status epilepticus in central nervous system infections: an experience from a developin...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-4
Journal Detail:
Title:  Schizophrenia research     Volume:  -     ISSN:  1573-2509     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804207     Medline TA:  Schizophr Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier B.V. All rights reserved.
Affiliation:
Faculty of Dental Medicine, University of Montreal, Montreal, Canada; University of Montreal Hospital Center (C.H.U. Montreal), Canada; Louis-H. Lafontaine Hospital, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Catch-up growth in children after repair of Tetralogy of Fallot.
Next Document:  Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administr...